Co-Morbidities Associated with Generalized Myasthenia Gravis: Improving Patient Quality of Life

Released On
October 11, 2021

Expires On
October 11, 2022

Media Type

Completion Time
60 minutes

Neurology, Ophthalmology, Primary Care


Scroll to the Bottom of this Information to Begin this Course

This activity is provided by EXCEL Continuing Education.

Supported by an independent educational grant from ARGENX PHARMACEUTICALS.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — 1.0 Contact Hour

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of neuromuscular, neuroimmunology, neuro-ophthalmology, other neurology specialists and allied healthcare professionals.

Program Overview

Significant developments are currently taking place in the treatment and management paradigm of patients with comorbid conditions associated with gMG creating knowledge gaps for translating these advances into clinical decision-making. This activity will focus on consensus recommendations on how to evaluate and manage comorbid conditions including tolerability of drugs as a therapeutic modality.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Identify potential common comorbid conditions associated with generalized myasthenia gravis (gMG)
  • Describe management challenges of associated comorbid conditions when treating patients with gMG
  • Evaluate the safety and efficacy of incorporating multiple pharmacologic treatments when managing patients with gMG



Nicholas J. Silvestri, MD, FAAN

Clinical Associate Professor of Neurology
Assistant Dean for Student and Academic Affairs
Department of Neurology
Jacobs School of Medicine and Biomedical Sciences
University at Buffalo/SUNY, Buffalo, NY

Physician Accreditation Statement

EXCEL Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physician Credit Designation

EXCEL Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The UEMS-EACCME® = European Union of Medical Specialists and European Accreditation Council for CME have mutual recognition agreements with the American Medical Association for live events and e-learning materials. European physicians can earn their ECMEC®s (European CME credits) by either attending a live presentation approved by an ACCME accredited provider such as EXCEL or participating in e-learning activities (on-demand webcasts) from accredited providers from the USA that have been certified for AMA PRA Category 1 Credits™.

Nursing Accreditation Statement

EXCEL is accredited by the Florida Board of Nursing, provider # 50-619, and designates this activity for 1 contact hour.

Disclosures of Conflicts of Interest

Nicholas J. Silvestri, MD, FAAN

  • Advisor: Alexion and Immunovant
  • Advisor and Speaker : Argenx and UCB

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Complete pre-test
  3. Participate in the online activity.
  4. Complete post-test
  5. Submit the evaluation form.
Certificates will be emailed to the participant

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

EXCEL Continuing Education requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.


This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Contact Information

For CME questions please contact: